SFSG
XBI icon

Stearns Financial Services Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Stearns Financial Services Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-50
Closed -$5K – 188
2018
Q3 		$5K Buy
+50
New +$4.85K ﹤0.01% 169

Other funds holding XBI

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Stearns Financial Services Group's XBI Position: Q4 2018 in Review

Stearns Financial Services Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2018, closing a stake of 50 shares — an estimated $5K sold.

Stearns Financial Services Group first reported a position in XBI in Q3 2018 and held it in 1 quarter. The position peaked at $5K in Q3 2018. 427 funds tracked by Wall St. Rank hold XBI as of Q4 2018.

  • Stearns Financial Services Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2018 after selling out during the quarter.
  • Stearns Financial Services Group sold 50 State Street SPDR S&P Biotech ETF shares in Q4 2018, an estimated $5K.
  • Stearns Financial Services Group first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and held it in 1 quarter.
  • Stearns Financial Services Group's State Street SPDR S&P Biotech ETF position peaked at $5K in Q3 2018.
  • 427 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2018.

Based on Stearns Financial Services Group's 13F filing for Q4 2018, filed 14 Feb 2019.